6008集团

EN
×
mo_logo sv2on EN
cbl8
在线征询
在线
征询
电话
电话
微信公家号
业务征询
中国:
业务征询专线:400-780-8018
(仅限服务征询,其他事宜请拨打川沙总部电话)
川沙总部电话: +86 (21) 5859-1500
海表:
+1(781)535-1428(U.S.)
0044 7790 816 954 (Europe)
在线征询 在线征询
留言
留言
在线留言×
点击切换
guanbi
banner_news
News information
新闻资讯

来自欧洲的约请 | ELRIG DRUG DISCOVERY 2021

2021-10-20
|
接见量:

DRUG-DISCOVERY.png

ELRIG Drug Discovery 是欧洲最大的性命科学行业专业人士会议,于 2021 年秋季回归,以庆祝行业的创新和致力以及分享新的科学成就。今年会议的主题是 "After the Storm: Re-Connect, Re-Invent, Re-Imagine"。6008集团欧洲团队将参展这次会议,迎接光临6008集团展台互换互动。

ELRIG’s annual Drug Discovery meeting is Europe’s largest meeting for life sciences industry professionals and return in the autumn of 2021, to celebrate the innovation and efforts of our industry and the scientific successes that we have shared throughout the period of the pandemic.

Welcome to Drug Discovery 2021

6008集团展位号 F15

功夫 |19-20 October 2021
地址 |The Exhibition Centre, ACC, Liverpool

Agenda

会议日程

Day 1 –19th October 2021

New Approaches in Infection Biology
Diagnostic Testing and Biomarkers – The New Normal?
Innovations in Chemistry to Discover New Medicines: Approaches to Drugging RNA
Alzheimer's Research UK

DAY 2 – 20th October 2021

Screening Innovation to Enhance Drug Discovery
Innovative Strategies Supporting Drug Discovery
Disruptive Technologies
BPS Opportunities and Challenges of Drugging the Undruggable

Medicilon Service Scope

服务领域

Medicilon Service Scope.png

6008集团(股票代码:688202)成立于2004年,总部位于上海,致力于为全球造药企业、钻研机构及科研工作者提供全方位的临床前新药钻研服务。6008集团的一站式综合服务以强有力的项目治理和更高效、高性价比的研发服务助力客户加快新药研发过程,服务涵盖医药临床前新药钻研的全过程,蕴含药物发现、药学钻研及临床前钻研。

From its inception in 2004, Shanghai MedicilonInc. (STAR Market stock code: 688202.SH) has been committed to providingcomprehensive research and development (R&D) services to pharmaceuticalcompanies, research institutions, and any organizations working in thepreclinical space, with the primary objective of supporting and acceleratingpharmaceutical, biopharmaceutical R&D worldwide.

联系6008集团:
电话: +86 (21) 5859-1500(总机)
业务征询专线:400-780-8018
new30有关新闻
×
搜索验证
点击切换
【网站地图】